3 ms·
In Norway, admitting usage of recreational cannabis to your doctor is likely to result in your driver's license being suspended as they are known to forward the
by jallasprit 5y ago
In Norway, admitting usage of recreational cannabis to your doctor is likely to result in your driver's license being suspended as they are known to forward the information on to police.
- krageon 5y agoAdvice to talk about it with your doctor is useless if you can just stop taking it. If you cannot (f.e. due to chronic pain), then you may as well stop worrying about it. Your doctor will not be able to magic anything away in either one of those scenarios.
- olyjohn 5y agoYou should still be able to be 100% honest and open with your doctor in regards to your health. The more they know about your health and habits, the better they can help you. Your doctor should not be ratting you out to the cops. That just keeps shit underground and untreated.
- krageon 5y ago> should not I agree, but the unfortunate fact is that it's not just Norway where you are one mistake away from being ratted out. General rules of thumb in this case should serve the individual. If you are very scared of drug interactions, you can just as easily find this information online.
- hirvi74 5y agoThe only caveat I would imagine with what you said is in the case of prescription drugs. Drugs of all kinds can have interactions when combined with together (both known and unknown), so disclosing the usage of non-prescribed supplements and alternative drugs can be vital information. However, in the case of the GP comment about Norway -- if there are legal ramifications, then I suppose this becomes a more complex issue to navigate. Though, if "socially unacceptable" drugs and their usages were not so stigmatized, this wouldn't be an issue either. One can see something like this in the US a bit. There is a somewhat rare condition called CHS (Cannabinoid Hyperemesis Syndrome) where chronic, long-term users of cannabinoid products develop a condition similar to Cyclical Vomiting Syndrome. For ER professionals, telling the difference between the two (and other GI issues) can be extremely difficult -- especially if the patient does not disclose their usage of cannabinoid products. Some ERs are starting to drug test patients exhibiting symptoms of CHS/CVS to help in the diagnostic process, so they do not have to rely on patient honesty.